These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14613496)

  • 1. Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy.
    Ponte-Sucre A
    Kinetoplastid Biol Dis; 2003 Oct; 2(1):14. PubMed ID: 14613496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
    Datta AK; Datta R; Sen B
    Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.
    Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR
    Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-induced chronic cholesterol depletion inhibits Leishmania donovani infection: Relevance of optimum host membrane cholesterol.
    Kumar GA; Roy S; Jafurulla M; Mandal C; Chattopadhyay A
    Biochim Biophys Acta; 2016 Sep; 1858(9):2088-2096. PubMed ID: 27319380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biology of host-parasite membrane interactions in leishmaniasis.
    Chang KP; Fong D
    Ciba Found Symp; 1983; 99():113-37. PubMed ID: 6357669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectivity and Drug Susceptibility Profiling of Different
    Baek KH; Piel L; Rosazza T; Prina E; Späth GF; No JH
    Pathogens; 2020 May; 9(5):. PubMed ID: 32443883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.
    Papadogiannakis EI; Koutinas AF
    Vet Immunol Immunopathol; 2015 Feb; 163(3-4):94-102. PubMed ID: 25555497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline leishmaniosis: Is the cat a small dog?
    Pennisi MG; Persichetti MF
    Vet Parasitol; 2018 Feb; 251():131-137. PubMed ID: 29426470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host.
    Naderer T; Vince JE; McConville MJ
    Curr Mol Med; 2004 Sep; 4(6):649-65. PubMed ID: 15357214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish Infection.
    Veras PS; Bezerra de Menezes JP
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies.
    Suzuki E; Tanaka AK; Toledo MS; Levery SB; Straus AH; Takahashi HK
    Biochim Biophys Acta; 2008 Mar; 1780(3):362-9. PubMed ID: 17976917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite.
    Sadeghi S; Seyed N; Etemadzadeh MH; Abediankenari S; Rafati S; Taheri T
    Korean J Parasitol; 2015 Aug; 53(4):385-94. PubMed ID: 26323836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Subcellular Localization of Leishmania Alba-Domain Proteins throughout the Parasite Development.
    Dupé A; Dumas C; Papadopoulou B
    PLoS One; 2015; 10(9):e0137243. PubMed ID: 26334886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intracellular cAMP in differentiation-coupled induction of resistance against oxidative damage in Leishmania donovani.
    Bhattacharya A; Biswas A; Das PK
    Free Radic Biol Med; 2008 Mar; 44(5):779-94. PubMed ID: 18078824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of heparan sulfate in host macrophage infection by
    Maciej-Hulme ML; Skidmore MA; Price HP
    Biochem Soc Trans; 2018 Aug; 46(4):789-796. PubMed ID: 29934302
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.